Members in the News
NOTE: News organizations may not keep articles permanently on their sites. As a result, links to news items that have expired may not work.
- Stephen Hecht, Ph.D., Carcinogenesis and Chemoprevention Program, in quoted in WCCO-TV, Salon , Gloucester Citizen, WATE stories about the formaldehyde risk in some e-cigarette vapor.
- Michael Verneris, M.D., Transplant Biology and Therapy Program, was quoted in stories about the 11-year old leukemia patient who refused chemotherapy. See Toronto Star, Hamilton Spectator, Inside Halton.
- Immuno-Oncology News reported on a new collaboration between Intrexon, ZIOPHARM, and M.D. Anderson to develop CAR T-cells immunotherapy. Sleeping Beauty gene transfer technology discovered and developed by Genetics Mechanism of Cancer Program member Perry Hackett, Ph.D., contributed to this breakthrough in cancer immunotherapy.
- Schelomo Marmor, Ph.D., is quoted in a Health Talk story about the impact of accreditation on centers for hematopoietic cell transplantation
- Dorothy Hatsukami, Ph.D., Prevention and Etiology Program, was among the authors of a joint policy statement on e-cigarettes issued by the American Association for Cancer Research and the American Society of Clinical Oncology. Read more. A number of media outlets reported on the statement’s release: WebMD, Medscape, Yale News, and Healio.
- The Academic Health Center’s Health Talk blog published a story on research by Emil Lou, M.D., Ph.D., Tumor Microenvironment Program,Subree Subramanian, Ph.D., and Clifford Steer, M.D., Genetic Mechanisms of Cancer Program, demonstrating for the first time that microRNAs can travel directly between cancer cells. This study was published in the November issue of Translational Research. Lou was the journal’s Featured New Investigator of the month.
- A Spring Grove Herald story on the Eagles Cancer Telethon mentions the Masonic Cancer Center, one of the recipients of the fundraising event.
- Dorothy Hatsukami, Ph.D., associate director of the Masonic Cancer Center’s Cancer Prevention and Control, is mentioned in MedPage Today OncoBriefs story about research that she and her colleagues reported in Cancer Prevention Reseasrch showing that smokeless tobacco increases exposure to carcinogens.
- Douglas Yee, M.D., Masonic Cancer Center director, commented on the potential for the use of immunotherapy drugs for the treatment of breast cancer for HemOnc Today’s Highlights from the San Antonio Breast Cancer Symposium. View the video.
- Dorothy Hatsukami, Ph.D., associate director of Cancer Prevention and Control, co-authored a commentary on smokeless tobacco that appeared in the Hindustan Times.
- Stephen Hecht, Ph.D., Carcinogenesis and Chemoprevention Program, was quoted in Mineral Wells Index, WPTV, Washington Post, and Tri-Valley Dispatch stories about the formaldehyde risk in e-cigarette vapor.